Opinion|Videos|October 28, 2024
Key Takeaways on the Future of HER2 in NSCLC
Panelists conclude by highlighting key takeaways in the management of NSCLC.
Advertisement
Episodes in this series
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Vutrisiran Effects Consistent With, Without Tafamidis in ATTR-CM
2
FDA Approves Camizestrant for ER+, HER2– mBC With ESR1 Mutations
3
Cardiac Risks of COVID-19 Vaccine vs Infection: Eman Toraih, MD, PhD
4
Multiagonists Outpace Older GLP-1 Drugs for Weight Loss
5